PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26944919-0	2016	Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.	edelfosine	0-10	activating transcription factor 3	Homo sapiens	81-85	
26944919-5	2016	Furthermore, edelfosine treatment inhibited the expression of androgen receptor (AR) and was associated with an increase in activating transcription factor 3 (ATF3) expression levels, a stress response gene and a negative regulator of AR transactivation.	edelfosine	13-23	activating transcription factor 3	Homo sapiens	124-157	
26944919-5	2016	Furthermore, edelfosine treatment inhibited the expression of androgen receptor (AR) and was associated with an increase in activating transcription factor 3 (ATF3) expression levels, a stress response gene and a negative regulator of AR transactivation.	edelfosine	13-23	activating transcription factor 3	Homo sapiens	159-163	
26944919-6	2016	ATF3 binds to AR after edelfosine + AD and represses the transcriptional activation of AR as demonstrated by PSA promoter studies.	edelfosine	23-33	activating transcription factor 3	Homo sapiens	0-4	
26944919-7	2016	Knockdown of ATF3 using siRNA-ATF3 reversed the inhibition of PSA promoter activity, suggesting that the growth inhibition effect of edelfosine was ATF3 dependent.	edelfosine	133-143	activating transcription factor 3	Homo sapiens	13-17	
26944919-7	2016	Knockdown of ATF3 using siRNA-ATF3 reversed the inhibition of PSA promoter activity, suggesting that the growth inhibition effect of edelfosine was ATF3 dependent.	edelfosine	133-143	activating transcription factor 3	Homo sapiens	30-34	
26944919-7	2016	Knockdown of ATF3 using siRNA-ATF3 reversed the inhibition of PSA promoter activity, suggesting that the growth inhibition effect of edelfosine was ATF3 dependent.	edelfosine	133-143	activating transcription factor 3	Homo sapiens	30-34